FDA Approves New Device for Chronic, Moderate-to-Severe Heart Failure

THURSDAY, March 21, 2019 -- The Optimizer Smart system was approved for treatment of patients with chronic, moderate-to-severe heart failure who are not eligible for treatment with other heart failure devices, including cardiac resynchronization...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news